Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 90 P644 | DOI: 10.1530/endoabs.90.P644

ECE2023 Poster Presentations Diabetes, Obesity, Metabolism and Nutrition (159 abstracts)

Evaluation of the Frequency of Exocrine Pancreatic Insufficiency in Patients With Diabetes Mellitus

Sadi Furkan Engürülü 1 , Nilüfer Özdemir 2 , Sedat Can Güney 2 , Serkan Erdal 3 , Fatma Taneli 3 , Elmas Kasap 4 & Zeliha Hekimsoy 2


1Manisa Celal Bayar University, Faculty of Medicine, Department of Internal Medicine, Manisa, Turkey; 2Manisa Celal Bayar University, Faculty of Medicine, Department of Endocrinology and Metabolism, Manisa, Turkey; 3Manisa Celal Bayar University, Faculty of Medicine, Department of Medical Biochemistry, Manisa, Turkey; 4Manisa Celal Bayar University, Faculty of Medicine, Department of Gastroenterology, Manisa, Turkey


Introduction and Aim: In our study, the frequency of exocrine pancreatic insufficiency, and its relationship with the duration of diabetes and the level of glycemic control and other complications of diabetes were investigated in patients with diabetes mellitus.

Materials and Methods: This paper was supported by Manisa Celal Bayar University Scientific Research Projects Coordination Unit, Project Number 2021-086. A total of 249 diabetic patients, 21 with type 1 diabetes mellitus, 2 with MODY, and the remaining 226 with type 2 diabetes mellitus, were included in this prospective study, between 15 September 2021 and 20 September 2022. The frequency of exocrine pancreatic insufficiency was investigated using fecal elastase-1 measurements in stool. Statistical evaluations were made with T test, Chi-square test and Kruskal Wallis test.

Results: In 20 patients, fecal elastase-1 levels were below 100 mg/ml and this was considered as severe exocrine pancreatic insufficiency. In 57 patients, fecal elastase-1 levels were found to be between 100-200 mg/ml and it is evaluated as mild-moderate exocrine pancreatic insufficiency. In total, exocrine pancreatic insufficiency was detected in 77 patients (30.9%). While mean duration of diabetes mellitus in 77 patients with exocrine pancreatic insufficiency was 11.34±9.42 years, the mean disease duration of 172 patients with normal fecal elastase levels was 9.06±7.81 years. The difference was found to be statistically significant (P=0.047). When glycemic control, duration of diabetes mellitus and exocrine pancreatic insufficiency were evaluated, exocrine pancreatic insufficiency was found more frequently in patients with HbA1c level above 8.5% (P=0.007) and in patients with diabetes mellitus for more than 15 years (P=0.018). In addition, when diabetes mellitus complications and exocrine pancreatic insufficiency were evaluated, exocrine pancreatic insufficiency was found more frequently in patients with diabetic retinopathy (P=0.033). No relation was found between neuropathy, nephropathy and coronary artery disease.

Conclusions: In our study, it was revealed that exocrine pancreatic insufficiency was more common as the duration of diabetes increased and glycemic control worsened. Exocrine pancreatic insufficiency was also found more frequently in patients with diabetic retinopathy. Although it is thought that exocrine pancreatic insufficiency may be one of the chronic complications of diabetes mellitus, further studies with more patients are needed.

Keywords: Diabetes mellitus, Exocrine Pancreatic Insufficiency, Fecal Elastase.

Volume 90

25th European Congress of Endocrinology

Istanbul, Turkey
13 May 2023 - 16 May 2023

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.